Patents by Inventor Sandra Merscher-Gomez
Sandra Merscher-Gomez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230338412Abstract: Described are methods for using cyclodextrin to treat, inhibit, prevent, ameliorate, or cure diabetes or conditions relating to diabetes.Type: ApplicationFiled: September 21, 2022Publication date: October 26, 2023Applicant: L&F RESEARCH LLCInventors: Alessia FORNONI, Sandra MERSCHER-GOMEZ
-
Publication number: 20210228616Abstract: Described are methods for using cyclodextrin to treat, inhibit, prevent, ameliorate, or cure diabetes or conditions relating to diabetes.Type: ApplicationFiled: January 22, 2021Publication date: July 29, 2021Applicant: L&F Research LLCInventors: Alessia Fornoni, Sandra Merscher-Gomez
-
Patent number: 10980828Abstract: Described are methods for using cyclodextrin to treat, inhibit, prevent, ameliorate, or cure diabetes or conditions relating to diabetes.Type: GrantFiled: December 20, 2018Date of Patent: April 20, 2021Assignee: L & F Research LLCInventors: Alessia Fornoni, Sandra Merscher-Gomez
-
Patent number: 10765697Abstract: Assays, methods and kits for predicting a subject's (e.g., human) risk of primary glomerulopathy, secondary glomerulopathy or recurrence (e.g., post-transplant recurrence) of any glomerular disease include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Assays for predicting if a diabetic subject will develop kidney disease or a patient with FSGS will develop recurrent disease after transplant also include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Also described herein are compositions and methods for treating and preventing the aforementioned disorders.Type: GrantFiled: December 20, 2018Date of Patent: September 8, 2020Assignee: L & F RESEARCH LLCInventors: Alessia Fornoni, Sandra Merscher-Gomez
-
Publication number: 20190262385Abstract: Described are methods for using cyclodextrin to treat, inhibit, prevent, ameliorate, or cure diabetes or conditions relating to diabetes.Type: ApplicationFiled: December 20, 2018Publication date: August 29, 2019Applicant: L&F Research LLCInventors: Alessia Fornoni, Sandra Merscher-Gomez
-
Publication number: 20190125780Abstract: Assays, methods and kits for predicting a subjects (e.g., human) risk of primary glomerulopathy, secondary glomerulopathy or recurrence (e.g., post-transplant recurrence) of any glomerular disease include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Assays for predicting if a diabetic subject will develop kidney disease or a patient with FSGS will develop recurrent disease after transplant also include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Also described herein are compositions and methods for treating and preventing the aforementioned disorders.Type: ApplicationFiled: December 20, 2018Publication date: May 2, 2019Applicant: L&F RESEARCH LLCInventors: Alessia FORNONI, Sandra MERSCHER-GOMEZ
-
Patent number: 10195227Abstract: Described are methods for using cyclodextrin to treat, inhibit, prevent, ameliorate, or cure diabetes or conditions relating to diabetes.Type: GrantFiled: April 12, 2013Date of Patent: February 5, 2019Assignee: L&F Research LLCInventors: Alessia Fornoni, Sandra Merscher-Gomez
-
Patent number: 10183038Abstract: Assays, methods and kits for predicting a subject's (e.g., human) risk of primary glomerulopathy, secondary glomerulopathy or recurrence (e.g., post-transplant recurrence) of any glomerular disease include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Assays for predicting if a diabetic subject will develop kidney disease or a patient with FSGS will develop recurrent disease after transplant also include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Also described herein are compositions and methods for treating and preventing the aforementioned disorders.Type: GrantFiled: December 14, 2015Date of Patent: January 22, 2019Assignee: L&F Research LLCInventors: Alessia Fornoni, Sandra Merscher-Gomez
-
Patent number: 10052345Abstract: Assays, methods and kits for predicting a subject's (e.g., human) risk of primary glomerulopathy, secondary glomerulopathy or recurrence (e.g., post-transplant recurrence) of any glomerular disease include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Assays for predicting if a diabetic subject will develop kidney disease or a patient with FSGS will develop recurrent disease after transplant also include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Also described herein are compositions and methods for treating and preventing the afore-mentioned disorders.Type: GrantFiled: October 14, 2011Date of Patent: August 21, 2018Assignee: University of MiamiInventors: Alessia Fornoni, George William Burke, Sandra Merscher-Gomez
-
Publication number: 20160220600Abstract: Assays, methods and kits for predicting a subject's (e.g., human) risk of primary glomerulopathy, secondary glomerulopathy or recurrence (e.g., post-transplant recurrence) of any glomerular disease include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Assays for predicting if a diabetic subject will develop kidney disease or a patient with FSGS will develop recurrent disease after transplant also include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Also described herein are compositions and methods for treating and preventing the aforementioned disorders.Type: ApplicationFiled: December 14, 2015Publication date: August 4, 2016Inventors: Alessia Fornoni, Sandra Merscher-Gomez
-
Publication number: 20150065457Abstract: Described are methods for using cyclodextrin to treat, inhibit, prevent, ameliorate, or cure diabetes or conditions relating to diabetes.Type: ApplicationFiled: April 12, 2013Publication date: March 5, 2015Applicant: L&F HEALTH LLCInventors: Alessia Fornoni, Sandra Merscher-Gomez
-
Publication number: 20130202601Abstract: Assays, methods and kits for predicting a subject's (e.g., human) risk of primary glomerulopathy, secondary glomerulopathy or recurrence (e.g., post-transplant recurrence) of any glomerular disease include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Assays for predicting if a diabetic subject will develop kidney disease or a patient with FSGS will develop recurrent disease after transplant also include examining cells for the presence or absence of cytoskeletal disruptions or rearrangements and examining cells for modulation of expression and/or activity of markers such as SMPDL-3b. Also described herein are compositions and methods for treating and preventing the afore-mentioned disorders.Type: ApplicationFiled: October 14, 2011Publication date: August 8, 2013Inventors: Alessia Fornoni, George William Burke, Sandra Merscher-Gomez